Stock Market
Biotech Stock on Verge of Triple-Digit Surge
By Bullbit Editorial ยท March 29, 2026
- WhatBiotech VK2735 GLP-1 weight loss drug candidate shows promise.
- WhyVK2735's efficacy could lead to significant market demand.
- SignalPositive clinical trial results expected to boost stock value.
- TargetYear-end price target of 300% increase in stock value.
- RiskUncertainty around regulatory approvals poses a risk to investment.
More breaking news โ